Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

Background The median age of prostate cancer diagnosis is 66 years, and the median age
of men who die of the disease is eighty years. The public health impact of prostate cancer is …

PURPOSE The aim of this work is to provide evidence-based guidance on the management
of osteoporosis in survivors of adult cancer. METHODS ASCO convened a multidisciplinary …

Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate
Cancer Patients Page 1 Downloaded from https://journals.lww.com/acsm-msse by …

PURPOSE In 2017, Cancer Care Ontario's Program in Evidence-Based Care released the
Bone Health and Bone-Targeted Therapies for Prostate Cancer guideline. This guideline …

Objectives To examine whether it is more efficacious to commence exercise medicine in
men with prostate cancer at the onset of androgen‐deprivation therapy (ADT) rather than …

Background Osteoporosis is a skeletal disorder characterized by compromised bone
strength, resulting in increased fracture risk. Patients with prostate cancer may have multiple …

Cancer and cancer therapies are a major factor risk for osteoporosis due to bone loss and
deterioration of bone microarchitecture. Both factors contribute to a decrease in bone …

Simple Summary Men with prostate cancer undergoing Androgen Deprivation Therapy
(ADT) have an increased risk of fractures. Despite this risk, fracture risk assessment is often …

Bone health impairment is a frequent detrimental consequence of the high bone tropism of
prostate cancer (PCa) cells. It is further worsened by administration of androgen-deprivation …